Evaluating the Effect of Neighborhood Environments on Cardiovascular Risk Factors

December 23, 2013 updated by: University of Colorado, Denver

Reducing CVD (Cardiovascular Disease) Risk and Health Disparities Through Active Living Communities

Cardiovascular disease (CVD) is one of the main causes of death in the United States. Research has shown that individuals who maintain an active lifestyle are less likely to develop CVD. This study will examine how neighborhood environments influence CVD risk factors of residents in and around the Stapleton community of Denver, Colorado.

Study Overview

Status

Completed

Conditions

Detailed Description

CVD is a major health problem in the United States. Individuals who live in an environment in which it is difficult to maintain an active lifestyle may be more at risk for developing CVD. Because of an increased interest in healthy living, urban planners and architects are now developing neighborhoods that are designed to encourage physical activity. Parks, walking and bicycle trails, wider sidewalks, and community recreation facilities are examples of amenities that are being included in these neighborhoods. By incorporating these enhancements, the Stapleton community in Denver, Colorado has been redeveloped as a more active living environment. The purpose of this study is to determine the effect of the neighborhood environment on the cardiovascular health of residents in five racially, ethnically, and socioeconomically diverse neighborhoods in or near the Stapleton community.

In Years 1 and 2 of this study, 200 households from each of the five neighborhoods will be randomly chosen to complete a survey regarding their cardiovascular health, physical activity level, and use and perception of their neighborhood environment and facilities, for a total of 1,000 surveys. Interviews and focus groups with members of the community will also be used to gather information. Additionally, a neighborhood council composed of community members will be formed to study disparities among the five neighborhoods in their use of their neighborhood environments, their physical activity levels, and their cardiovascular risk factors. In Year 2, study researchers will analyze the collected data and distribute the findings within the communities. They will also begin testing culturally and community relevant programs aimed at reducing CVD risk factors.

Study Type

Observational

Enrollment (Actual)

1140

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Denver
      • Denver, Colorado, United States, 80217
        • University of Colorado Denver

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Residents of one of the following five neighborhoods in the Greater Stapleton Community: Northeast Park Hill, Greater Park Hill, East Montclair, Stapleton, or Original Aurora

Description

Inclusion Criteria:

  • Live in one of the following five neighborhoods in the Greater Stapleton Community: Northeast Park Hill, Greater Park Hill, East Montclair, Stapleton, or Original Aurora
  • Speak either English or Spanish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Effect of the neighborhood environment on the cardiovascular health of residents
Time Frame: Measured during Years 1 and 2 of the study
Measured during Years 1 and 2 of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Colorado, Denver

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Investigators

  • Principal Investigator: Debbi S. Main, PhD, University of Colorado, Denver

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2006

Primary Completion (Actual)

May 1, 2009

Study Completion (Actual)

May 1, 2009

Study Registration Dates

First Submitted

August 4, 2006

First Submitted That Met QC Criteria

August 4, 2006

First Posted (Estimate)

August 8, 2006

Study Record Updates

Last Update Posted (Estimate)

December 25, 2013

Last Update Submitted That Met QC Criteria

December 23, 2013

Last Verified

December 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 06-0264
  • R21HL083866 (U.S. NIH Grant/Contract)
  • R21HL083866-01 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe